Condition
Intracranial Atherosclerosis ICAS
Total Trials
3
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
P 4 (1)
Trial Status
Unknown1
Not Yet Recruiting1
Active Not Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT07466251Phase 4Not Yet Recruiting
PCSK9 Inhibitor for Intracranial Atherosclerosis Related Acute Ischemic Stroke
NCT07309705Active Not RecruitingPrimary
Digital Angiography-Derived Fractional Flow Assessment for Intracranial Stenosis
NCT03719820Unknown
Stroke Imaging Package Study of Intracranial Atherosclerosis ( SIPS-ICAS )
Showing all 3 trials